Research graph
References from Argentine consensus on the clinical utility of breath tests and small intestinal bacterial overgrowth management in patients with disorders of gut-brain interaction. Local targets link to admitted publications; unresolved targets remain external evidence.
The gut microbiome in disorders of gut-brain interaction
10.1080/19490976.2024.2360233 · 2024 · External reference
Rome IV-functional GI disorders: disorders of gut-brain interaction
10.1053/j.gastro.2016.03.035 · 2016 · External reference
Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV
2016 · External reference
The role of psychological factors in functional gastrointestinal disorders: a systematic review and meta-analysis
10.1007/s00384-023-04333-9 · 2023 · External reference
Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome
10.1053/j.gastro.2011.07.043 · 2011 · External reference
Gut microbiota signatures and modulation in irritable bowel syndrome
2022 · External reference
Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders
10.1038/s41467-019-09964-7 · 2019 · External reference
Contribution of MicroRNAs in the development of irritable bowel syndrome symptoms
10.15403/jgld-4676 · 2023 · External reference
Clinical experience with the use of anti-CdtB and anti-vinculin antibodies in patients with diarrhea in Mexico
2016 · External reference
Small intestinal bacterial overgrowth-pathophysiology and its implications for definition and management
10.1053/j.gastro.2022.04.002 · 2022 · External reference
Vasoactive intestinal polypeptide plays a key role in the microbial-neuroimmune control of intestinal motility
10.1016/j.jcmgh.2023.11.012 · 2024 · External reference
A role for the gut microbiota in IBS
10.1038/nrgastro.2014.40 · 2014 · External reference
Small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis of case-control studies
10.14309/ajg.0000000000000504 · 2020 · External reference
Hydrogen and methane-based breath testing in gastrointestinal disorders: the norTH AMERICAN consensus
10.1038/ajg.2017.46 · 2017 · External reference
10.1002/ueg2.12133
10.1002/ueg2.12133 · 2022 · External reference
Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference
2009 · External reference
Clinically relevant breath tests in gastroenterological diagnostics--recommendations of the German Society for Neurogastroenterology and Motility as well as the German Society for Digestive and Metabolic Diseases
10.1055/s-2005-858479 · 2005 · External reference
Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: an initiative of the Indian Neurogastroenterology and Motility Association
10.1007/s12664-022-01292-x · 2022 · External reference
Using a modified nominal group technique as a curriculum evaluation tool
2004 · External reference
Metodología de calificación y resumen de las opiniones dentro de consensos formales
2009 · External reference
Unresolved reference
External reference
Methods of formal consensus in classification/diagnostic criteria and guideline development
10.1016/j.semarthrit.2010.12.001 · 2011 · External reference
A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro-cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients
10.1111/nmo.12331 · 2014 · External reference
Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS
10.1136/gut.2009.205476 · 2011 · External reference
Scintigraphy demonstrates high rate of false-positive results from glucose breath tests for small bowel bacterial overgrowth
10.1016/j.cgh.2015.07.032 · 2016 · External reference
Pros and cons of breath testing for small intestinal bacterial overgrowth and intestinal methanogen overgrowth
2023 · External reference
Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome
10.1001/jama.292.7.852 · 2004 · External reference
Glucose malabsorption associated with rapid intestinal transit
1992 · External reference
A systematic review of diagnostic tests for small intestinal bacterial overgrowth
10.1007/s10620-007-0065-1 · 2008 · External reference
Breath tests for the non-invasive diagnosis of small intestinal bacterial overgrowth: a systematic review with meta-analysis
10.5056/jnm19113 · 2020 · External reference
Abnormal breath testing in IBS: a meta-analysis
10.1007/s10620-010-1276-4 · 2010 · External reference
Diagnostic reliability of glucose and lactulose breath tests: insights from a test-retest study in healthy adults
10.1111/nmo.70089 · 2025 · External reference
Modern concepts of small intestinal bacterial overgrowth
10.1097/mog.0000000000001135 · 2025 · External reference
Diagnosis and management of small intestinal bacterial overgrowth
10.1177/0884533613485882 · 2013 · External reference
Fasting hypochlorhydria with gram positive gastric flora is highly prevalent in healthy old people
10.1136/gut.33.10.1331 · 1992 · External reference
Spectrum and antibiotic sensitivity of bacteria contaminating the upper gut in patients with malabsorption syndrome from the tropics
10.1186/1471-230x-3-9 · 2003 · External reference
Duodenal bacterial overgrowth during treatment in outpatients with omeprazole
10.1136/gut.35.1.23 · 1994 · External reference
Small intestinal bacterial overgrowth: clinical features and therapeutic management
10.14309/ctg.0000000000000078 · 2019 · External reference
Defining small intestinal bacterial overgrowth by culture and high throughput sequencing
10.1016/j.cgh.2023.06.001 · 2024 · External reference
Evaluating breath methane as a diagnostic test for constipation-predominant IBS
10.1007/s10620-009-0778-4 · 2010 · External reference
Methanogenic flora is associated with altered colonic transit but not stool characteristics in constipation without IBS
10.1038/ajg.2009.655 · 2010 · External reference
Understanding our tests: hydrogen-methane breath testing to diagnose small intestinal bacterial overgrowth
10.14309/ctg.0000000000000567 · 2023 · External reference
Stability of human methanogenic flora over 35 years and a review of insights obtained from breath methane measurements
10.1016/j.cgh.2005.11.006 · 2006 · External reference
La medición simultánea de hidrógeno y metano mejora el rédito diagnóstico del test de aire espirado en el Sobrecrecimiento microbiano intestinal
10.52787/agl.v53i4.320 · 2023 · External reference
Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: a systematic review and meta-analysis
10.1080/19490976.2021.1933313 · 2021 · External reference
Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity
10.1152/ajpgi.00574.2004 · 2006 · External reference
Accurate identification of excessive methane gas producers by a single fasting measurement of exhaled methane: a large-scale database analysis
10.14309/00000434-201510001-01787 · 2015 · External reference
Competition for hydrogen by human faecal bacteria: evidence for the predominance of methane producing bacteria
10.1136/gut.32.12.1498 · 1991 · External reference
AGA clinical practice update on small intestinal bacterial overgrowth: expert review
10.1053/j.gastro.2020.06.090 · 2020 · External reference
Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis
10.1016/j.cgh.2009.06.031 · 2009 · External reference
Positive glucose breath testing is more prevalent in patients with IBS-like symptoms compared with controls of similar age and gender distribution
10.1097/mcg.0b013e3181a099a5 · 2009 · External reference
The role of diagnostic testing in irritable bowel syndrome
10.1016/j.gtc.2010.12.001 · 2011 · External reference
Small intestinal bacterial overgrowth in patients with interstitial cystitis and gastrointestinal symptoms
10.1007/s10620-007-0022-z · 2008 · External reference
Small intestinal bacterial overgrowth in children: a state-of-the-art review
10.3389/fped.2019.00363 · 2019 · External reference
Comparison of abdominal bloating severity between Irritable Bowel Syndrome patients with high and low levels of breath hydrogen excretion in a lactulose breath test
2012 · External reference
ACG clinical guideline: small intestinal bacterial overgrowth
10.14309/ajg.0000000000000501 · 2020 · External reference
The degree of breath methane production in IBS correlates with the severity of constipation
10.1111/j.1572-0241.2007.01072.x · 2007 · External reference
Evaluation of lactulose, lactose, and fructose breath testing in clinical practice: a focus on methane
10.1002/jgh3.12240 · 2019 · External reference
Methodology of the H2 breath test. I. Collection and storage for gas measurement
1990 · External reference
Storage of breath samples for H2 analyses
10.1016/0016-5085(88)90260-0 · 1988 · External reference
Assessment of the influence of hydrogen nonexcretion on the usefulness of the hydrogen breath test and lactose tolerance test
1996 · External reference
Effect of predominant methanogenic flora on the outcome of lactose breath test in irritable bowel syndrome patients
10.1038/sj.ejcn.1601651 · 2003 · External reference
Acidic colonic microclimate--possible reason for false negative hydrogen breath tests
10.1136/gut.29.1.21 · 1988 · External reference
Delayed analysis of hydrogen-methane breath samples
10.5223/pghn.2022.25.1.13 · 2022 · External reference
The brain-gut axis in abdominal pain syndromes
10.1146/annurev-med-012309-103958 · 2011 · External reference
Diagnostic utility of carbohydrate breath tests for SIBO, fructose, and lactose intolerance
10.1007/s10620-019-05889-9 · 2020 · External reference
The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS
10.1136/gutjnl-2017-313750 · 2017 · External reference
Colon hypersensitivity to distension, rather than excessive gas production, produces carbohydrate-related symptoms in individuals with irritable bowel syndrome
10.1053/j.gastro.2016.09.062 · 2017 · External reference
Fermentable sugar ingestion, gas production, and gastrointestinal and central nervous system symptoms in patients with functional disorders
10.1053/j.gastro.2018.07.013 · 2018 · External reference
Development and validation of the paediatric Carbohydrate Perception Questionnaire (pCPQ), an instrument for the assessment of carbohydrate-induced gastrointestinal symptoms in the paediatric population
10.1111/nmo.13934 · 2020 · External reference
Carbohydrate-induced gastrointestinal symptoms: development and validation of a test-specific symptom questionnaire for an adult population, the adult Carbohydrate Perception Questionnaire
10.1097/meg.0000000000001880 · 2021 · External reference
Understanding the significant interaction between hydrogen and methane in the performance and interpretation of breath testing
10.1016/s0016-5085(15)32493-8 · 2015 · External reference
Efficacy and findings of a blinded randomized reintroduction phase for the low FODMAP diet in irritable bowel syndrome
10.1053/j.gastro.2024.02.008 · 2024 · External reference
Prevalence of excessive intestinal methane production and its variability with age and gender: a large-scale database analysis
10.1016/s0016-5085(15)32494-x · 2015 · External reference
Phenotype and antibiotic response in patients with flat line breath test results: a large scale database analysis: 448
10.14309/00000434-201810001-00448 · 2018 · External reference
Measurement of hydrogen sulfide during breath testing correlates to patient symptoms
10.1016/s0016-5085(17)30993-9 · 2017 · External reference
Shedding light on elevated baseline hydrogen and flat-line patterns during breath testing
10.14309/ajg.0000000000000659 · 2020 · External reference
Phenotype and antibiotic response in patients with elevated baselinE. hydrogen breath test results: a large-scale database analysis
2019 · External reference
What is the optimal threshold for an increase in hydrogen and methane levels with glucose breath test (GBT) for detection of small intestinal bacterial overgrowth (SIBO)?
10.1016/s0016-5085(14)61927-2 · 2014 · External reference
Pattern of methane levels with lactulose breath testing; can we shorten the test duration?
10.1002/jgh3.12592 · 2021 · External reference
Small intestinal bacterial overgrowth: current update
10.1097/mog.0000000000000971 · 2023 · External reference
Update on the role of rifaximin in digestive diseases
10.15403/jgld-4871 · 2023 · External reference
Rifaximin-alpha increases lactase activity in patients with irritable bowel syndrome without constipation and small intestinal bacterial overgrowth
10.1007/s10620-024-08767-1 · 2025 · External reference
Diferencias farmacocinéticas entre rifaximina alfa y una rifaximina genérica
2019 · External reference
Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024
2025 · External reference
Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth
10.1111/apt.13928 · 2017 · External reference
Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth
10.1111/apt.12479 · 2013 · External reference
Symptomatic response to antibiotics in patients with small intestinal bacterial overgrowth: a systematic review and meta-analysis
10.5056/jnm22187 · 2024 · External reference
Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome: an evidence-based review
2014 · External reference
Rifaximin therapy for patients with irritable bowel syndrome without constipation
10.1056/nejmoa1004409 · 2011 · External reference
Diet and intestinal bacterial overgrowth: Is there evidence?
10.12998/wjcc.v10.i15.4713 · 2022 · External reference
A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test
10.1097/mcg.0b013e3181c64c90 · 2010 · External reference
Antibiotic treatment of constipation-predominant irritable bowel syndrome
10.1007/s10620-014-3157-8 · 2014 · External reference
Probiotics for preventing and treating small intestinal bacterial overgrowth: a meta-analysis and systematic review of current evidence
10.1097/mcg.0000000000000814 · 2017 · External reference
A comprehensive review of the usefulness of prebiotics, probiotics, and postbiotics in the diagnosis and treatment of small intestine bacterial overgrowth
10.3390/microorganisms13010057 · 2025 · External reference
Probiotics, prebiotics & synbiotics in small intestinal bacterial overgrowth: opening up a new therapeutic horizon!
2014 · External reference
Low-dose nocturnal tegaserod or erythromycin delays symptom recurrence after treatment of irritable bowel syndrome based on presumed bacterial overgrowth
2009 · External reference
Repeat treatment with rifaximin is safe and effective in patients with diarrhea-predominant irritable Bowel Syndrome
10.1053/j.gastro.2016.08.003 · 2016 · External reference
